{"name":"Procept BioRobotics","slug":"procept","ticker":"PRCT","exchange":"NASDAQ","domain":"procept-biorobotics.com","description":"PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","hq":"Redwood City, CA","founded":0,"employees":"888","ceo":"Reza Zadno","sector":"MedTech / Surgical Robotics / Urology","stockPrice":26.09,"stockChange":0.39,"stockChangePercent":1.52,"marketCap":"$1.5B","metrics":{"revenue":322024000,"revenueGrowth":20.2,"grossMargin":64,"rdSpend":71277000,"netIncome":-95572000,"cash":245640992,"dividendYield":0,"peRatio":-29.6,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Procept BioRobotics Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Procept BioRobotics reported fourth quarter and full year 2023 financial results, with revenue of $13.4 million and a net loss of $13.6 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Procept BioRobotics Announces Partnership with Medtronic to Develop Next-Generation Urology Robotics Platform","summary":"Procept BioRobotics announced a partnership with Medtronic to develop a next-generation urology robotics platform.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"Procept BioRobotics Receives FDA Clearance for Aquablation System","summary":"Procept BioRobotics received FDA clearance for its Aquablation system, a minimally invasive treatment for BPH.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWUxuMm15VF9XTlpKb2JmakFwSktfSnNPUzFBNFpiUHR0R1NPaGNTeDBzX0dOX3pOUmZkS0E1TGNOUzdfTGZLMEVmR1lXd3lzWkhjR2tidGpwY0ROWl8xZ05BQXFOb2NzWTh6VmJMdmtXUmNNMDI1TGV3QThPNHVTRVZ2SmpmaVhpMVo5a0NCcHh2eFFvN2MxOTBwdHBEUWxvNG5Ud2VIMnVRZw?oc=5","date":"2026-03-30","type":"pipeline","source":"Seeking Alpha","summary":"PROCEPT BioRobotics: An Undervalued Surgical Robotics Growth Story (NASDAQ:PRCT) - Seeking Alpha","headline":"PROCEPT BioRobotics: An Undervalued Surgical Robotics Growth Story (NASDAQ:PRCT)","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQNHcwQUhTdjJ5ZUhIQi1TRlZXZTJoNllGb2V2NjdXNnJycnVGMDNCX3lya1VsTFhHWm9vVy0yUEYtT29qNW0tTGNjQXZENjVnUkhJc1dadmRHSFhpczB6ak1GamplOHJFR3lnaFpUNV91bk16dWw3d0x3NTgtQ0V3LXpMZHkwRTNXejU5VUNwQVRfa3hHNmhCbVRFNHlYNlVJc0FScmxDTDFMVkZjSEQzOVNkdDJEeDQ?oc=5","date":"2026-03-02","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Monday's After-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQQ3dnZ0V2emRSZ05rZVA3WlN3bEduQ3JFTkdRSzhFSGl1T0FKTFpiTG9pRllHZURDQlh1TjBSMWNRWDlkN0o5NldRY1g1bHRHV1NTbWxnOWx0clp6ZGJ0Wldacnd1Ty1kejVmVWxTNFY1NEpoRmNMUDZuMk9IVVdqc2ZCVTAyamREUkRBQktvX2h2Z1pZNjdYcENBTFZveUZj0gGoAUFVX3lxTE1TTC0wOGtCZjE0WVo4OTUwRE12LUhQcnJqRi1MTDBpaUs3S3BRX0l3YlR5MXZrS1BoLTd4d3RYbS1LcVpldGtkcENCVmFIOTFpMkdvaUJkQ2RwWXdlckZZaU9vWktXa2xVNHByR0oyVGZwTTI5QmJmWnB4WTJCZnEyX2p5ZURFTUhHT2RhcmJfWWhDRTBxakdlMWdpOUJTWmNTd0huN1F0bA?oc=5","date":"2026-02-24","type":"pipeline","source":"Insider Monkey","summary":"PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory - Insider Monkey","headline":"PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNOUQybkpZMnN6QXRQRFlWZ00wemlrMWZFamM4aUMtYU50NURFdHJlb3BNN052QXpBOFZqOUM0NkdGVThoUUVlYWtuUllRX0t4VmpfUkNxZkNydEdOWjZHX2RaS1ZsdnhJa01rdUFJQ3FBQklXYzRZZi1FQnpPcllEY3R3QnN0SXhudlpESERxVzhWakp6dzRTYUdvOWE5S1dEWjNCcHdfS0o0R3NSY3JhUFhWQ1VUYXZh?oc=5","date":"2026-02-23","type":"earnings","source":"Stock Titan","summary":"Inclement weather delays PROCEPT BioRobotics Q4 call, Investor Day - Stock Titan","headline":"Inclement weather delays PROCEPT BioRobotics Q4 call, Investor Day","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOOUVsVXZsTmlpUWhKbWZyc2tLX0YwbUpIV1lhaXdwTlNjQ01qVTBIb1FPRDcteTFlb2xXX3Z1QlExQlcxTWVWSXRqQW5HRmZPaFEzVDRhZE5nc1g2V3l0bVlrUkhXekMzckVyOWFLclZKaWVTVjBoSVRXeU9hTVpFRzRRNVRqdlRVQVpTMkctZTFhSDZ5TEpnWWUzZ1VzNG5mdEdHaDB5MFotU2ZIbHlQTDRFb2t1WmpHeENsd2Nybw?oc=5","date":"2025-10-15","type":"earnings","source":"Stock Titan","summary":"Q3 2025 results on Nov. 4 — PROCEPT BioRobotics to Host 4:30 p.m. ET Conference Call and Webcast - Stock Titan","headline":"Q3 2025 results on Nov. 4 — PROCEPT BioRobotics to Host 4:30 p.m. ET Conference Call and Webcast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPLUQyd0cxS2pfbkM5VE1RQ2IxaWNfVXNEVjRmU1NGSHNiMG9lRWgxSUJOdktkbVpoX2FmRFhVaFRvTmlURE5vVmtQTUs4MkJsQThzQnlXWUxFOERNR292eEpsMXhtbm04MW83a1NIZDJ0WjdJWHgwRkpuM0t5TzBNVHNIS3Q1YlU0eVhoQUJ4a28zYXA2ZTl4T21kT3NjYjRwemNBcEJBVEVueXJx?oc=5","date":"2025-10-06","type":"pipeline","source":"Seeking Alpha","summary":"Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader (PRCT) - Seeking Alpha","headline":"Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader (PRCT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQcGxXZF9OWnBFYzBMS0ZHWWZMTlRyU1BkNEhlQzlYeENjNXQ4bG0xQTAzMzBXRFdfNzVOdl9vbGVqVDg2RU4yY0laNzdEbnNUWlpMRUlDcmpMZER6Q0pyaE1HYm0zaDFRZ3RQVWtrQkJmNnNzVG5oNUxGRmdWNTNIMC12eEktcXpBX2FJdA?oc=5","date":"2025-06-05","type":"pipeline","source":"StocksToTrade","summary":"Procept BioRobotics’ Unexpected Surge: Market Insights - StocksToTrade","headline":"Procept BioRobotics’ Unexpected Surge: Market Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFAxWDNpdjZrYVFtd1QzRzJWWEVGUG9yS21ZWXE2NjczOXRQdDBmRkVENmxHNXhQQkFiM1RaSHNEQlMwQU1PSnVnOFRaOWNhMDVoTkxDLWkydFFybXVySm9sVjlINVdNRGxNUnVJYTdwREl2bkg4a0ZhZ3ZNWFI?oc=5","date":"2025-05-19","type":"deal","source":"Nanalyze","summary":"PROCEPT BioRobotics Stock Takes a Breather. Is It a Buy? - Nanalyze","headline":"PROCEPT BioRobotics Stock Takes a Breather. Is It a Buy?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNMWh6bk1mQW5aSGdXQWE1Xy1wWU9odXE1cWxlWUdWLXN3dk1nbG45cTlRRkV2Q29RWEFCbU1QamZYTjhIMnktSFZOVnpKOWVCM05ndk81dWtRVXdMLVRWZTJTYXJGRjF3TjQzQ0pWYTM1RzJDeHZfTzZMTkt6cUVfaHpDT0FrbUROQ1luMndQWVNvc0cwdzUxVzVac1BxcF80V09LTU1la3JUSXhvcUhnZWduMTY1ZnJQS2VkSzBmWGx1dWxsUGdOOQ?oc=5","date":"2025-03-11","type":"earnings","source":"Seeking Alpha","summary":"Procept BioRobotics Q4: Strong Growth, But Profitability Seems Far Away (NASDAQ:PRCT) - Seeking Alpha","headline":"Procept BioRobotics Q4: Strong Growth, But Profitability Seems Far Away (NASDAQ:PRCT)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQaTFLdXV2OUxlbzhsMXNvNVJtSmg5OThFbmY0U3B0cWVOVVUzVGp2ZF8xa2RsLXhBd1dyZ2g4alRLMjhZRmFITEJPWUtKRjl6VmJIT2p3UjJrekVnaWE2bUxlejQ3RnBGWUJ5WWVSSFk5dVZkYnZrcC1vV3BqTFdKLUprc2hnNHRWYk1INWNrSlczaklLZFo4cw?oc=5","date":"2024-11-06","type":"pipeline","source":"Stockhouse","summary":"Top 10 pharmaceutical AI stocks | 2024-11-06 | Investing News - Stockhouse","headline":"Top 10 pharmaceutical AI stocks | 2024-11-06 | Investing News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5mNnlQWmxFRUdPRVRXVGhOclNfdTNPUVdla2JIN1ByTElPY1Q1cGs2V2RfZklxU3VTTVgzd3R0ZkZxNXhXS0xINmxYbWdPMzdi?oc=5","date":"2024-02-28","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPUk9Da0JzT1czcFRRVEtKYnRtYmhKOGN3bVF0Sl8yQ0xzbV9LWVVRWGtDeGg0NE9CdVhVNER5Sko5VHRBYUUxV241bHpYbzZET0xxazhPQjVaNGs2aVg0Rmc3dTdYUlN0QXdEbzkwQ2J1RXRTSUhHQlB3el9XbXczRVdR?oc=5","date":"2023-02-13","type":"pipeline","source":"Barron's","summary":"JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics. - Barron's","headline":"JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics. - Barron's","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Boston Scientific","Medtronic","Intuitive Surgical"],"therapeuticFocus":["Urology","Surgical Robotics"],"financials":{"source":"sec_edgar+yahoo","revenue":308054000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":308054000,"period":"2025-12-31"},{"value":224498000,"period":"2024-12-31"},{"value":224498000,"period":"2024-12-31"},{"value":136191000,"period":"2023-12-31"},{"value":136191000,"period":"2023-12-31"}],"grossProfit":196226000,"grossProfitHistory":[{"period":"2025-12-31","value":196226000},{"period":"2024-12-31","value":137099000},{"period":"2023-12-31","value":71049000},{"period":"2022-12-31","value":37085000}],"rdSpend":71277000,"rdSpendHistory":[{"period":"2025-12-31","value":71277000},{"period":"2024-12-31","value":62298000},{"period":"2023-12-31","value":48446000},{"period":"2022-12-31","value":28981000}],"sgaSpend":228808000,"operatingIncome":-103859000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-103859000},{"period":"2024-12-31","value":-96614000},{"period":"2023-12-31","value":-109170000},{"period":"2022-12-31","value":-80724000}],"netIncome":-95572000,"netIncomeHistory":[{"period":"2025-12-31","value":-95572000},{"period":"2024-12-31","value":-91413000},{"period":"2023-12-31","value":-105897000},{"period":"2022-12-31","value":-87154000}],"eps":-1.72,"epsHistory":[{"period":"2025-12-31","value":-1.72},{"period":"2024-12-31","value":-1.75},{"period":"2023-12-31","value":-2.24},{"period":"2022-12-31","value":-1.96}],"cash":286503000,"cashHistory":[{"period":"2025-12-31","value":286503000},{"period":"2024-12-31","value":333725000},{"period":"2023-12-31","value":257222000},{"period":"2022-12-31","value":221859000}],"totalAssets":508081000,"totalLiabilities":142211000,"totalDebt":78483000,"equity":365870000,"operatingCashflow":-48985000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-48985000},{"period":"2024-12-31","value":-99213000},{"period":"2023-12-31","value":-108003000},{"period":"2022-12-31","value":-80382000}],"capex":-9356000,"capexHistory":[{"period":"2025-12-31","value":-9356000},{"period":"2024-12-31","value":-4409000},{"period":"2023-12-31","value":-25206000},{"period":"2022-12-31","value":-2653000}],"freeCashflow":-58341000,"dividendsPaid":null,"buybacks":null,"employees":888,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":65088000,"ebit":-30863000,"ebitda":-29128000,"period":"2026-03-31","revenue":83132000,"epsBasic":-0.56,"netIncome":-31638000,"rdExpense":21465000,"epsDiluted":-0.56,"grossProfit":53947000,"operatingIncome":-32606000},{"sga":58298000,"ebit":-28761000,"ebitda":-27052000,"period":"2025-12-31","revenue":76383000,"epsBasic":-0.53,"netIncome":-29845000,"rdExpense":19056000,"epsDiluted":-0.53,"grossProfit":46313000,"operatingIncome":-31041000},{"sga":59011000,"ebit":-20492000,"ebitda":-18874000,"period":"2025-09-30","revenue":83327000,"epsBasic":-0.38,"netIncome":-21411000,"rdExpense":18187000,"epsDiluted":-0.38,"grossProfit":54006000,"operatingIncome":-23192000},{"sga":56303000,"ebit":-18683000,"ebitda":-17095000,"period":"2025-06-30","revenue":79182000,"epsBasic":-0.35,"netIncome":-19578000,"rdExpense":17632000,"epsDiluted":-0.35,"grossProfit":51746000,"operatingIncome":-22189000},{"sga":55197000,"ebit":-23907000,"ebitda":-22432000,"period":"2025-03-31","revenue":69162000,"epsBasic":-0.45,"netIncome":-24737000,"rdExpense":16402000,"epsDiluted":-0.45,"grossProfit":44161000,"operatingIncome":-27438000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":26.09,"previousClose":25.7,"fiftyTwoWeekHigh":66.85,"fiftyTwoWeekLow":19.35,"fiftyTwoWeekRange":"19.35 - 66.85","fiftyDayAverage":25.14,"twoHundredDayAverage":32.03,"beta":0.83,"enterpriseValue":1295169280,"forwardPE":-29.6,"priceToBook":4.27,"priceToSales":4.61,"enterpriseToRevenue":4.02,"enterpriseToEbitda":-12.65,"pegRatio":0,"ebitda":-102377000,"ebitdaMargin":-31.8,"freeCashflow":-43175248,"operatingCashflow":-70132000,"totalDebt":77996000,"debtToEquity":22.4,"currentRatio":6.73,"returnOnAssets":-13.5,"returnOnEquity":-27.8,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":9,"targetMeanPrice":30.44,"targetHighPrice":37,"targetLowPrice":20,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":3.1,"institutionHeldPercent":106.5,"sharesOutstanding":56918844,"floatShares":55587512,"sharesShort":6004339,"shortRatio":4.37,"shortPercentOfFloat":10.6,"epsTrailing":-1.83,"epsForward":-0.88,"revenuePerShare":5.76,"bookValue":6.11,"officers":[{"age":59,"name":"Mr. Larry L. Wood","title":"President, CEO & Director"},{"age":48,"name":"Mr. Kevin  Waters","title":"Executive VP & CFO"},{"age":46,"name":"Ms. Alaleh  Nouri","title":"EVP, Chief Legal Officer & Corporate Secretary"},{"age":55,"name":"Mr. Christofer  Christoforou","title":"Executive Vice President of Operations"},{"age":null,"name":"Mr. Barry  Templin","title":"Executive VP & CTO"},{"age":null,"name":"Mr. Matthew James Bacso C.F.A.","title":"Vice President of Investor Relations"},{"age":null,"name":"Ms. Pooja Sharma Rao","title":"Executive VP and Chief Strategy & Marketing Officer"},{"age":50,"name":"Ms. Stacey L. Porter","title":"Executive VP & Chief People Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.procept-biorobotics.com","phone":"650 232 7200"}}